Edition:
India

Immunovia AB (publ) (IMMNOV.ST)

IMMNOV.ST on Stockholm Stock Exchange

171.80SEK
22 Mar 2019
Change (% chg)

2.80kr (+1.66%)
Prev Close
169.00kr
Open
169.20kr
Day's High
172.00kr
Day's Low
169.00kr
Volume
8,141
Avg. Vol
16,649
52-wk High
273.50kr
52-wk Low
98.90kr

Latest Key Developments (Source: Significant Developments)

Immunovia Q4 Pretax Loss Widens To SEK 25.7 Mln
Thursday, 14 Feb 2019 

Feb 15 (Reuters) - Immunovia AB ::REPORTED ON THURSDAY Q4 NET SALES SEK 91,000 VS SEK 26,000 YR AGO.Q4 PRETAX LOSS SEK 25.7 MLN VS LOSS SEK 15.3 MLN YR AGO.CO'S FINANCIAL TARGETS REMAIN IN PLACE FROM THE PREVIOUS QUARTER.EXPECTS TO RECEIVE THE FIRST REVENUES FROM SELF-PAY SALES IN THE LATTER PART OF 2019.TARGET IS TO ACHIEVE TURNOVER OF SEK 250-300 MILLION BY 2022 BASED ON SELF-PAY FOR IMMRAY PANCAN–D.TARGET IS TO ACHIEVE TOTAL TURNOVER, INCLUDING PAYMENT VIA SELF-PAY AND COST REMUNERATION FROM INSURANCE SYSTEMS, OF SEK 800-1,000 MILLION BY 2024.  Full Article

Immunovia Q2 Operating Loss Sek 27.2 Million
Friday, 24 Aug 2018 

Aug 24 (Reuters) - Immunovia AB (publ) ::Q2 NET SALES SEK 44,000 VERSUS SEK 68,000 YEAR AGO.Q2 OPERATING LOSS SEK 27.2 MILLION VERSUS LOSS SEK 10.6 MILLION YEAR AGO.  Full Article

Immunovia: Karolinska Institutet To Participate In Pancreatic Cancer Study
Friday, 3 Aug 2018 

Aug 3 (Reuters) - Immunovia AB (publ) ::KAROLINSKA INSTITUTET PARTICIPATES IN IMMUNOVIA'S PANFAM-1 PROSPECTIVE CLINICAL STUDY FOR EARLY DETECTION OF PANCREATIC CANCER USING BLOOD-BASED TEST.  Full Article

Immunovia Approved For Listing On Nasdaq Stockholm
Monday, 26 Mar 2018 

March 26 (Reuters) - IMMUNOVIA AB (PUBL) ::IMMUNOVIA HAS BEEN APPROVED FOR LISTING ON NASDAQ STOCKHOLM.‍FIRST DAY OF TRADING ON NASDAQ STOCKHOLM IS SCHEDULED FOR 3 APRIL 2018​.‍LAST DAY OF TRADING ON NASDAQ FIRST NORTH IS SCHEDULED FOR 29 MARCH 2018​.  Full Article

Immunovia Q3 net loss widens to SEK 11.6 mln‍​
Friday, 10 Nov 2017 

Nov 10 (Reuters) - IMMUNOVIA AB (PUBL) :NET SALES FOR Q3 2017 WERE SEK 27 THOUSAND (5 K)‍​.THE NET LOSS FOR Q3 2017 WAS SEK 11,589 THOUSAND (-4,048 K)‍​.  Full Article

Immunovia gets SEK 4.9 mln grant from Swelife Accelerator Innovation Program
Monday, 30 Oct 2017 

Oct 30 (Reuters) - IMMUNOVIA AB (PUBL) ::IMMUNOVIA RECEIVES SEK4.9 MILLION GRANT FROM SWELIFE ACCELERATOR INNOVATION PROGRAM.  Full Article

Immunovia starts cooperation with ‍Linköping University Medical Faculty ​
Monday, 23 Oct 2017 

Oct 23 (Reuters) - IMMUNOVIA AB (PUBL) :STARTS COOPERATION WITH ‍LINKÖPING UNIVERSITY MEDICAL FACULTY ​.  Full Article

BRIEF-Immunovia Q4 Pretax Loss Widens To SEK 25.7 Mln

* REPORTED ON THURSDAY Q4 NET SALES SEK 91,000 VS SEK 26,000 YR AGO